Darzalex, which treats multiple myeloma, has become the first Johnson & Johnson drug to ever top $3 billion in quarterly sales.
As the industry gathers at Paris Fashion Week, bosses are eyeing a revival in demand across the Atlantic to kick-start a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback